MedPlus reins in staff incentives after aggressive private-label medicine selling
MedPlus Health Services has scaled back staff incentives that encouraged aggressive recommendations of its private-label medicines. The pharmacy chain plans to shift promotion to advertising, influencers and staff training, with private-label mix expected to stabilise this quarter before gradually recovering.
MedPlus scaled back staff incentives that led to aggressive private-label medicine recommendations. The pharmacy retailer will instead use advertising, influencers and better staff training to promote lower-cost alternatives, expecting private-label sales mix to stabilise this quarter before gradually recovering.
Why this matters
The incentives reset follows MedPlus reporting a 22% profit decline despite 22% revenue growth and expanding to 5,476 stores. It also follows its ₹100 crore+ commitment to a Hyderabad concierge healthcare pilot.
Retail-brand signals are accelerating, up +343700% QoQ.